| 0.2 |
0.9 |
GO:1903615 |
regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.1 |
0.5 |
GO:0060298 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) positive regulation of sarcomere organization(GO:0060298) |
| 0.1 |
0.5 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.1 |
0.3 |
GO:0035948 |
N-terminal peptidyl-lysine acetylation(GO:0018076) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.1 |
0.2 |
GO:1902362 |
melanocyte apoptotic process(GO:1902362) |
| 0.1 |
0.2 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 |
0.3 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.0 |
0.2 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 |
0.1 |
GO:0046022 |
positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.0 |
0.0 |
GO:0035378 |
carbon dioxide transmembrane transport(GO:0035378) |
| 0.0 |
0.2 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.0 |
0.3 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 |
0.2 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.0 |
0.1 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.0 |
0.2 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.0 |
0.6 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.1 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.0 |
0.1 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.0 |
0.3 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.2 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.0 |
0.2 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.0 |
0.1 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.0 |
0.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.1 |
GO:0097359 |
UDP-glucosylation(GO:0097359) |
| 0.0 |
0.0 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.0 |
0.1 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.0 |
0.1 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.0 |
0.1 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.0 |
0.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.3 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.0 |
0.1 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.0 |
0.1 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.0 |
0.2 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.0 |
0.1 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.0 |
0.2 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 |
0.1 |
GO:0048389 |
apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) deltoid tuberosity development(GO:0035993) intermediate mesoderm development(GO:0048389) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) pattern specification involved in mesonephros development(GO:0061227) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in kidney development(GO:0072098) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.0 |
1.4 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.0 |
0.1 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 |
0.1 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.0 |
0.0 |
GO:2000502 |
negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.0 |
0.1 |
GO:2000435 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.0 |
0.1 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.0 |
0.1 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.0 |
0.1 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.0 |
0.0 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.0 |
0.1 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.0 |
0.1 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 0.0 |
0.0 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.0 |
0.2 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.0 |
0.0 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.0 |
0.1 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.0 |
0.1 |
GO:1903764 |
regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.0 |
0.0 |
GO:0042853 |
L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.0 |
0.0 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.0 |
0.1 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.0 |
0.1 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 |
0.1 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.0 |
0.0 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.0 |
0.1 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
